About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

2 Cheap Stocks The Insiders Are Buying

By: MarketBeat

Stocks Insiders are buying

Aspira Women’s Health and Genesco have both seen their share prices implode. The plunges spurred the insiders to act and buy shares. The purchases are all the more telling because there has been no insider activity in either stock for many quarters, and both have catalysts on the horizon. 

Aspira Women’s Health Turning A Corner 

Aspira Women’s Health has seen better days. Its shares are down nearly 100% from $140 to $2 over the last 2 years due to continued failure to deliver revenue and earnings. However, a new strategy appears to be gaining momentum, and the insiders are buying.

The company implemented a new marketing and sales strategy that resulted in a record increase in new ordering physicians. The company’s core products are a suite of tests for gynecologic diseases, a market valued at nearly $15 billion. 

Key highlights of the Q1 report include volume per rep doubling and total revenue growing by 26%. Revenue was underpinned by a 29% increase in OvaSuite sales, and leverage was gained too. The company’s cash burn also subsided and was 44% less than the prior year. Assuming this momentum continues, the company could reach profitability within the next few years. 

Aspira Women’s Health has 2 potential catalysts ahead. The 1st is the expanded use of the OvaWatch as a serial test which would greatly expand the addressable market. The 2nd is the launch of the 1st generation EndoCheck blood test.

The EndoCheck blood test is a non-invasive test for endometriosis and could add significantly to the top and bottom lines. 

Regarding the insiders. Insiders hadn’t made a sale or purchase of stock since the middle of 2022, and then in July of this year, 5 insiders made purchases on the same day. Insiders include the CEO, COO, CFO, director, and a major investor. That investor is Jack W. Shuler, who is a well-known pharma investor and philanthropist. Together, insiders own about 5% of the company. 

The chart isn’t awesome. The stock is in a clear downtrend and may continue to trend lower. However, the market is also oversold and showing signs of support at the current levels. Those signs include rising volume and diverging stochastic, which suggest overextension. 

Aspira Stock Price chart

Genesco Hits Rock Bottom

Shares of hit rock bottom following the fiscal Q1 earnings report and a rebound in play. The plunge was caused by weaker-than-expected earnings and reduced guidance now priced into the market.

The post-release action smacks of capitulation, meaning a meaningful rally could be brewing. Regardless, the insiders viewed the drop as a compelling opportunity and used it to buy shares. The insiders hadn’t made a purchase or sale in over a  year until Q2 when 4, including the CEO, CFO, VP, and a director, all made purchases.

The 1st three made their buys on the same day while the director waited until the following week. The salient point is that the stock is at a bottom and, like the business, at a turning point. 

Institutions may provide a headwind. The institutions own nearly 90% of the stock and sold heavily following the Q1 release. The activity has slacked off since but remains bearish on balance.

The next catalyst will be Q2 results expected at the end of this month.

The stock shows solid support at a critical level; the Q2 results may spark a retest of support, but it is expected to hold. Coincidentally, the single analyst with a rating on Insidertrades.com screening tools is bullish.

Seaport upped the stock to Buy earlier this year but did not set a price target with the release. However, it is trading in line with Footlocker’s valuation, which the analysts view as undervalued. 

More News

View More
Vertiv Stock Surges on Strategic CFO Hire and AI Momentum
Via MarketBeat
Topics Artificial Intelligence
Tickers NVDA VRT WAB
Tempus AI Hits $100—Are Shares Due for a Pullback?
Via MarketBeat
Topics Artificial Intelligence Government Initial Public Offering
Tickers TEM
3 More Hot Tech Stocks With Bullish Charts and Ample Upside
Via MarketBeat
Topics Artificial Intelligence
Tickers AMD AMZN IONQ MSFT ORCL QBTS
Johnson & Johnson Stock Can Keep Rising as Strategy Pays Off
Via MarketBeat
Tickers JNJ
Walmart's AI Play: OpenAI Deal Forges a New Path to Profitability
Via MarketBeat
Topics Artificial Intelligence
Tickers COST TGT WMT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.